Regulators pave way for dissimilar drug breakthrough

LONDON/ZURICH (Reuters) - European regulators have cleared the way for the first serious threat to the makers of multibillion-dollar biotechnology drugs to treat diseases such as cancer and rheumatoid arthritis. The European Medicines Agency (EMA)...

Source: http://health.yahoo.net/news/s/nm/regulators-pave-way-for-dissimilar-drug-breakthrough

source here i found it found it for you found it